reviews of noom glp 1 jumps into off-brand weight loss drug market GLP-1 Weight Loss Journey: 2

Because your stomach capacity and appetite are reduced, every bite needs to count nutritionally

What can be said is that the triple-agonist mechanism appears to produce a steeper dose-response curve than either the dual-agonist (tirzepatide) or single-agonist (semaglutide) approach

Lancet Diabetes Endocrinol 2018;6(2):105113

I hit protein like it was a second job, aiming well past what Id ever eaten before

Outcome studies show that GLP-1 medicines reduce rates of complications associated with T2D and/or obesity, including cardiovascular diseases, metabolic dysfunctionassociated liver diseases, chronic kidney disease, osteoarthritis, and obstructive sleep apnea (Figure 1)